The U.S. Food and Drug Administration is asking consumers to check their medicine cabinets after thousands of bottles of blood pressure medications were recalled nationwide.
According to the FDA website, New Jersey-based Macleods Pharma USA is recalling certain lots of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets.
The recall was issued on October 7, 2026, with the FDA subsequently instituting a Class II classification on October 26, 2026. A Class II recall means that use of the affected drug may result in “temporary or medically reversible adverse health consequences.”
Related video: How to stay ahead of reminders
Officials said the recall affected 3,528 30-count bottles from Lot 12251163A and 216 90-count bottles from Lot 12251163B. Both bundles expire on May 31, 2027.
A law enforcement report said the drug did not meet quality standards, meaning the pills did not dissolve as required in testing.
The recall comes after Inventia Healthcare recalled certain lots of chlorthalidone tablets in June. Then, on September 3, 2026, the company issued a separate recall for an additional lot of the drug. On September 17, 2026, the FDA classified the September recall as Class II.
Gn Health
